Category Archives: Corporate News / Blog

IFATS Recommendations for FDA Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products

International Federation of Adipose Therapeutics and Sciences (IFATS) 45 Lyme Road - Suite 304 Hanover, NH 03755 USA Tel: 1-603-643-2325, Fax: 1-603-643-1444   September 26, 2016   Division of Dockets Management (HFA–305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852   Re: FDA-2014-D-1856 - Comments to 2014-2015 Draft Guidance regarding: Docket…
Read more

Scientists Confirm Reprogrammed Adult Stem Cells Identical to Embryonic Stem Cells

Click on photo (at left) to enlarge Photo: iPS cells feature - reprogrammed stem cells: Credit: Moscow Institute of Physics and Technology Russian researchers have concluded that reprogramming does not create differences between reprogrammed and embryonic stem cells. Stem cells are specialized, undifferentiated cells that can divide and have the remarkable potential to develop into many different cell…
Read more

Breakthrough in scaling up life-changing stem cell production

Scientists from the U.K. and Sweden have discovered a new method of creating human stem cells that could solve the problem of meeting large-scale production needs, allowing researchers to fully realize the potential of stem cells for understanding and treating disease. Human pluripotent stem cells are undifferentiated cells that have the unique potential to develop…
Read more

Purest Liver-like Cells to Date Generated from Induced Pluripotent Stem Cells (iPSCs)

Researchers from the Medical University of South Carolina (MUSC) and the University of Pennsylvania have discovered a new methodology for purifying liver cells generated from induced pluripotent stem cells (iPSCs) that could facilitate progress toward an important clinical goal: treating patients with disease-causing liver mutations by transplanting unmutated liver cells derived from their own stem…
Read more